Evidence map›Paper›PMID 22827251›Full record

ReviewCardiovascular & hematological agents in medicinal chemistry2012

On the role of endothelial TRPC3 channels in endothelial dysfunction and cardiovascular disease.

K Smedlund, M Bah, G Vazquez

Abstract readReview
In one paragraph

Review in Cardiovascular & hematological agents in medicinal chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.2field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. The odyssey of the TR(i)P journey to the cellular membrane.Frontiers in cell and developmental biology · 2024
    Review
  2. Cracking the Endothelial Calcium (CaInternational journal of molecular sciences · 2023
    Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Cenerimod, a novel selective S1PPharmacology research & perspectives · 2017
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

K SmedlundDepartment of Physiology and Pharmacology, College of Medicine, University of Toledo Health Science Campus, 3000 Arlington Av, Toledo, OH 43614, USA.
M Bah
G Vazquez
University of Toledo · US

Funding

TRPC3 Channels in Molecular and Cellular Events of AtherogenesisR01HL111877 · NHLBI · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI VAZQUEZ, GUILLERMO · 2012 to 2015
$1.5M
NHLBI NIH HHS R01 HL111877NHLBI NIH HHS R01HL111877-01
6 · The paper itself

Abstract

In endothelium, calcium (Ca(2+)) influx through plasma membrane Ca(2+)-permeable channels plays a fundamental role in several physiological functions and in the pathogenesis of cardiovascular disease. Current knowledge on the influence of Ca(2+) influx in signaling events associated to endothelial dysfunction has grown significantly over recent years, particularly after identification of members of the Transient Receptor Potential Canonical (TRPC) family of channel forming proteins as prominent mediators of Ca(2+) entry in endothelial cells. Among TRPC members TRPC3 has been at the center of many of these physiopathological processes. Progress in elucidating the mechanism/s underlying regulation of endothelial TRPC3 and characterization of signaling events downstream TRPC3 activation are of most importance to fully appreciate the role of this peculiar cation channel in cardiovascular disease and its potential use as a therapeutic target. In this updated review we focus on TRPC3 channels, revising and discussing current knowledge on channel expression and regulation in endothelium and the roles of TRPC3 in cardiovascular disease in relation to endothelial dysfunction.

Indexed as

Cardiovascular DiseasesEndotheliumHumansTRPC Cation ChannelsTRPC3 cation channelTRPC Cation Channels

Identifiers

PMID22827251
PMCPMC3465809
OpenAlexW2106695534

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.